We are live on ! Find out more
WST icon

West Pharmaceutical
WST

309 hedge funds and large institutions have $6.36B invested in West Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 140 increasing their positions, 90 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $577K

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

56% more repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 90

17% more capital invested

Capital invested by funds: $5.45B → $6.36B (+$918M)

5% more funds holding

Funds holding: 294 → 309 (+15)

0.56% more ownership

Funds ownership: 90.99% → 91.55% (+0.56%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
309
Holders Change
+15
Holders Change %
+5.1%
% of All Funds
7.7%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
44
Increased
140
Reduced
90
Closed
25
Calls
$1.37M
Puts
$577K
Net Calls
+$793K
Net Calls Change
+$673K

Top Buyers

1
RP
Riverbridge Partners
Minnesota
+$47M
2
BlackRock
BlackRock
New York
+$38M
3
Renaissance Technologies
Renaissance Technologies
New York
+$28.9M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
5
Prudential Financial
Prudential Financial
New Jersey
+$22.1M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$34.7M
2
Millennium Management
Millennium Management
New York
-$29.1M
3
CRCP
Copper Rock Capital Partners
Massachusetts
-$28.2M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$25.7M
5
EAM
Eagle Asset Management
Florida
-$21.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
GWI
101
Grace & White Inc
New York
$4.4M -$414K -4,500 -9%
AG
102
Aperio Group
California
$4.28M +$1.35M +14,632 +48%
ERSOT
103
Employees Retirement System of Texas
Texas
$4.16M -$736K -8,000 -15%
Canada Life
104
Canada Life
Manitoba, Canada
$4.12M +$46.9K +510 +1%
RCG
105
Ruane, Cunniff & Goldfarb
New York
$4.04M -$1.56M -16,948 -28%
GIA
106
GHP Investment Advisors
Colorado
$3.85M +$1.01K +11 +0%
GIM
107
Granahan Investment Management
Massachusetts
$3.52M +$279K +3,032 +9%
Envestnet Asset Management
108
Envestnet Asset Management
Illinois
$3.46M +$1.52M +16,525 +82%
MSA
109
Mason Street Advisors
Wisconsin
$3.4M +$122K +1,322 +4%
Federated Hermes
110
Federated Hermes
Pennsylvania
$3.31M -$262K -2,848 -8%
OAM
111
Oppenheimer Asset Management
New York
$3.29M +$2.13M +23,118 +198%
Kayne Anderson Rudnick Investment Management
112
Kayne Anderson Rudnick Investment Management
California
$3.26M +$327K +3,560 +11%
USAA
113
United Services Automobile Association
Texas
$3.23M – – –
Ohio Public Employees Retirement System (OPERS)
114
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.15M -$4.69K -51 -0.2%
VRS
115
Virginia Retirement Systems
Virginia
$3.02M +$662K +7,200 +29%
AAM
116
Advisors Asset Management
Colorado
$2.99M -$67.8K -737 -2%
ASRS
117
Arizona State Retirement System
Arizona
$2.93M +$46K +500 +2%
SIM
118
Spark Investment Management
New York
$2.91M – – –
SOMRS
119
State of Michigan Retirement System
Michigan
$2.86M +$46K +500 +2%
Credit Agricole
120
Credit Agricole
France
$2.82M +$1.91M +20,816 +231%
BNP Paribas Financial Markets
121
BNP Paribas Financial Markets
France
$2.75M +$1.18M +12,833 +79%
LMGAM
122
Liberty Mutual Group Asset Management
Massachusetts
$2.7M -$418K -4,542 -14%
MERSOM
123
Municipal Employees' Retirement System of Michigan
Michigan
$2.68M -$508K -5,520 -16%
AIM
124
Assured Investment Management
New York
$2.68M -$1.41M -15,281 -35%
VOYA Investment Management
125
VOYA Investment Management
Georgia
$2.67M -$54.8K -596 -2%
3 4
5
6 7

WST Hedge Fund Activity: Q2 2017 in Review

309 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2017, worth a combined $6.36B — up 17% from $5.45B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new WST positions and 25 closed out — a net gain of 19 holders — while 140 added to existing stakes and 90 trimmed.

The largest buyer was Riverbridge Partners, opening a new position worth an estimated $47M. The largest seller was Victory Capital Management, cutting an estimated $34.7M.

  • 309 institutional investors held West Pharmaceutical (WST) as of Q2 2017, up from 294 in Q1 2017.
  • Funds reported $6.36B of West Pharmaceutical stock for Q2 2017, up 17% quarter-over-quarter.
  • 44 funds opened new West Pharmaceutical positions in Q2 2017 and 25 closed out, a net change of +19 holders.
  • The largest West Pharmaceutical buyer in Q2 2017 was Riverbridge Partners, an estimated $47M added.
  • The largest West Pharmaceutical seller in Q2 2017 was Victory Capital Management, an estimated $34.7M sold.

Based on aggregated 13F filings for Q2 2017.